“Novo Nordisk Is Up, But the Market Is Not Rational!” – Jim Cramer on Novo Nordisk A/S (NVO)
We recently published a list of Jim Cramer Discusses These 11 Stocks & President Trump’s Approval Drop. In this article, we ...
FiercePharma19h
Fierce Pharma Asia—Novo Nordisk's fraud accusation; AstraZeneca's China deal; Ono's FDA nod
Novo Nordisk alleges Singaporean biotech KBP Biosciences made misleading statements before the two firms inked a licensing ...
Hosted on MSN18d
Jim Cramer Expects Novo Nordisk A/S (NVO) To Forecast A Good 2025
As expected, the tariffs were announced, 25% from Mexico and Canada, and 10% from China ... Cramer mentioned that he expects Novo Nordisk A/S (NYSE:NVO) to forecast a good 2025 like its peer, Eli ...
Novo Nordisk alleges fraud after $1.3 billion deal to buy hypertension drug from KBP Biosciences
Novo Nordisk is seeking up to $830 million in damages from KBP Biosciences, according to a ruling by a Singapore court, as ...
Novo Nordisk Annual Sales Jump on Higher Demand for Obesity Drugs
The Danish maker of Ozempic and Wegovy reported a 25 percent increase in sales to $40.6 billion, but said it expected slower growth this year.
Bloomberg L.P.16d
Novo Nordisk Is Prepared for Trump’s Tariff Threat, CEO Says
Novo Nordisk A/S is prepared for potential tariffs ... Trump has threatened tariffs on key trading partners Canada, Mexico and China, which has left some manufacturing companies scrambling to ...
The Motley Fool8d
Why Novo Nordisk Stock Keeps Going Down
Competition from Him & Hers Health seems to be weighing on Novo Nordisk's stock. A half-hearted rating from Morgan Stanley yesterday isn't cheering investors up very much at all. Yet a new study ...